Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Drug Discov Today. 2008 May 5;13(11-12):530–535. doi: 10.1016/j.drudis.2008.03.018

Table 1.

Generic Paediatric Antiretroviral Fixed-dose Combinations (FDC)

Trade name1 FDC2 Concentration Manufacturer
Dual combinations
Coviro-LS Kid d4T+3TC 5 mg+20 mg Ranbaxy, India
Coviro-LS Kid DS d4T+3TC 10 mg+40 mg Ranbaxy, India
Emduo Junior d4T+3TC 10 mg+40 mg Emcure, India
Emduo Suspension d4T+3TC 10 mg+40 mg per 5 ml Emcure, India
Lamivir S Baby d4T+3TC 6 mg+30 mg Cipla, India
Lamivir S Junior d4T+3TC 12 mg+60 mg Cipla, India
Triple combinations
Emtri Junior d4T+3TC+NVP 10 mg+40 mg+70 mg Emcure, India
Emtri Suspension d4T+3TC+NVP 10 mg+40 mg+70 mg per 5 ml Emcure, India
GPOvir-S73 d4T+3TC+NVP 7 mg+30 mg+50 mg GPO, Thailand
Triommune Baby4 d4T+3TC+NVP 6 mg+30 mg+50 mg Cipla, India
Triommune Junior4 d4T+3TC+NVP 12 mg+60 mg+100 mg Cipla, India
Triviro-LNS Kid5 d4T+3TC+NVP 5 mg+20 mg+35 mg Ranbaxy, India
Triviro-LNS Kid DS5 d4T+3TC+NVP 10 mg+40 mg+70 mg Ranbaxy, India
Avocomb-N Kid5 AZT+3TC+NVP 60 mg+30 mg+60 mg Ranbaxy, India
GPOvir-Z306 AZT+3TC+NVP 30 mg+15 mg+28 mg GPO, Thailand
1

All drugs are in tablet form, unless otherwise noted.

2

d4T – stavudine; 3TC – lamivudine; NVP – nevirapine; AZT – zidovudine.

3

Phase I/II

4

FDA tentative approval and WHO prequalified

5

Under WHO review

6

Phase I, 2008 (planned)